Last checked at 11 Jun 2018 17:12
11 June 2018 |
Advanced Medical Solutions Group plc
("AMS", the "Company" or the "Group")
Director/PDMR Shareholding
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that it was notified on 6 June 2018 that Pieter van Hoof, who is a Senior Manager and PDMR, following the successful achievement of certain performance criteria, has exercised 36,375 options from the Long Term Incentive Plan (LTIP). Mr van Hoof has also, following the end of the holding period, exercised 4,643 options from the Deferred Annual Bonus Plan (DAB). Mr van Hoof elected to receive an additional 58 dividend shares which were earned during the 3 year holding period under the terms of the scheme. Mr van Hoof has also elected to exercise 13,608 Ordinary Shares of 5p from the Deferred Share Bonus Plan.
Mr van Hoof subsequently sold 61,488 Ordinary Shares of 5p each on 6 June 2018 at a share price of 330.50p per Ordinary Share. As a result of these transactions Pieter van Hoof's beneficial interest in the Company has decreased from 127,208 shares to 120,404 shares.
Long Term Incentive Plan (LTIP)
PDMR | No. of LTIPs prior to exercise | LTIPs exercised | Ordinary Shares sold | Ordinary Shares retained | LTIPs after exercise |
Pieter van Hoof | 108,300 | 36,375 | 36,375 | Nil | 71,925 |
Deferred Annual Bonus Plan (DAB)
PDMR | DABs prior to exercise | DABs exercised | Dividend Shares received | Ordinary Shares sold | Ordinary Shares retained | DABs after exercise |
Pieter van Hoof | 18,809 | 4,643 | 58 | 4,701 | Nil | 14,166 |
Deferred Share Bonus Plan (DSB)
PDMR | No. of DSBs prior to exercise | DSBs exercised | Ordinary Shares sold | Ordinary Shares retained | DSBs after exercise |
Pieter van Hoof | 28,818 | 13,608 | 13,608 | Nil | 15,210 |
Overall Holding
PDMR | Holding prior to exercise | Number of shares exercised | Dividend Shares received | Number of shares sold | Sale price (p) | Resultant holding | % of issued share capital |
Pieter van Hoof | 127,208 | 54,626 | 58 | 61,488 | 330.50p | 120,404 | 0.056% |
The Company further announces that it was notified on 6 June 2018 that Simon Coates, who is a Senior Manager and PDMR, elected to exercise 9,518 Ordinary Shares of 5p from the Deferred Share Bonus Plan (DSB). Mr Coates subsequently sold 4,490 Ordinary Shares of 5p each on 6 June 2018 at a share price of 330.50p per Ordinary Share to cover the tax and National Insurance payable on this exercise. As a result of these transactions Simon Coates's beneficial interest in the Company has increased from 97,581 shares to 102,609 shares.
Deferred Share Bonus Plan (DSB)
PDMR | No. of DSBs prior to exercise | DSBs exercised | Ordinary Shares sold | Ordinary Shares retained | DSBs after exercise |
Simon Coates | 39,736 | 9,518 | 4,490 | Nil | 30,218 |
Overall Holding
PDMR | Holding prior to exercise | Number of shares exercised | Number of shares sold | Number of shares retained | Sale price (p) | Resultant holding | % of issued share capital |
Simon Coates | 97,581 | 9,518 | 4,490 | 5,028 | 330.50p | 102,609 | 0.048% |
The Company further announces that it was notified on 8 June 2018 that Steve Bellamy, who is a Director and PDMR, transferred the legal ownership of his shares from ADM Investors Nominees Limited to HSBC Global Custody Nominee (UK) Limited. The number of shares held by Steve Bellamy and the beneficial ownership of the shares remains unchanged.
Overall Holding
PDMR | Holding prior to exercise | Number of shares sold | Sale price (p) | Resultant holding | % of issued share capital |
Steve Bellamy | 100,000 | Nil | - | 100,000 | 0.047% |
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1. | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name: Pieter van Hoof | ||||
2. | Reason for the notification | ||||
a) | Position/status: Senior Manager/PDMR | ||||
b) | Initial notification/Amendment: Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name: Advanced Medical Solutions Group plc | ||||
b) | LEI: 213800HJP6OWOSZI1L74 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 | ||||
b) | Nature of the transactions: · Exercise of 36,375 shares from the Long Term Incentive Plan · Exercise of 4,643 shares from the Deferred Annual Bonus Plan · Award of 58 Dividend Shares from the Deferred Annual Bonus Plan · Exercise of 13,608 shares from the Deferred Share Bonus Plan · Sale of 61,488 Ordinary Shares of 5p | ||||
c) | Price(s) and volume(s): Sale of shares:
| ||||
d) | Aggregated information: (Relates to those shares sold only) Aggregated volume: 61,488 Aggregated price: £3.305 | ||||
e) | Date of the transaction: 06/06/2018 | ||||
f) | Place of the transaction: London Stock Exchange, AIM Market (XLON) |
1. | Details of the person discharging managerial responsibilities/person closely associated | ||||
a) | Name: Simon Coates | ||||
2. | Reason for the notification | ||||
a) | Position/status: Senior Manager/PDMR | ||||
b) | Initial notification/Amendment: Initial Notification | ||||
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name: Advanced Medical Solutions Group plc | ||||
b) | LEI: 213800HJP6OWOSZI1L74 | ||||
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a) | Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 | ||||
b) | Nature of the transactions: · Exercise of 9,518 shares from the Deferred Share Bonus Plan · Sale of 4,490 Ordinary Shares of 5p | ||||
c) | Price(s) and volume(s): Sale of shares:
| ||||
d) | Aggregated information: (Relates to those shares sold only) Aggregated volume: 4,490 Aggregated price: £3.305 | ||||
e) | Date of the transaction: 06/06/2018 | ||||
f) | Place of the transaction: London Stock Exchange, AIM Market (XLON) |
1. | Details of the person discharging managerial responsibilities/person closely associated |
a) | Name: Steve Bellamy |
2. | Reason for the notification |
a) | Position/status: Director/PDMR |
b) | Initial notification/Amendment: Initial Notification |
3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) | Name: Advanced Medical Solutions Group plc |
b) | LEI: 213800HJP6OWOSZI1L74 |
4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) | Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594 |
b) | Nature of the transactions: · Transfer of legal ownership of 100,000 Ordinary Shares of 5p |
c) | Price(s) and volume(s): Sale of shares: Nil |
d) | Aggregated information: (Relates to those shares sold only) Aggregated volume: Nil Aggregated price: Nil |
e) | Date of the transaction: 08/06/2018 |
f) | Place of the transaction: London Stock Exchange, AIM Market (XLON) |
-End -
For further information, please visit www.admedsol.com or contact:
Advanced Medical Solutions Group plc | Tel: +44 (0) 1606 545508 |
Chris Meredith, Chief Executive Officer Mary Tavener, Chief Financial Officer | |
Consilium Strategic Communications | Tel: +44 (0) 20 3709 5700 |
Mary-Jane Elliott / Matthew Neal / Nicholas Brown | AMS@consilium-comms.com |
Investec Bank PLC (NOMAD & Broker) | Tel: +44 (0) 20 7597 5970 |
Daniel Adams / Patrick Robb / Gary Clarence |
About Advanced Medical Solutions Group plc - see www.admedsol.com
AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under white label.
AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia. Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.